These and the present findings reinforce the notion that regions associated with cholinergic attention, executive, ventral visual and salience networks appear central to the pathophysiology of cognition in DLB, and therefore represent promising treatment targets with mAChR or nAChR agonists. Here, CHRNA4 is linked to Lewy body dementia.